Lexapro vs. Cytomel: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Lexapro and Cytomel. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 157,190 people who take Lexapro and Cytomel, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
157,190 people who take Lexapro and Cytomel are studied.
What is Lexapro?
Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 84,135 Lexapro users for its effectiveness, alternative drugs and more.
What is Cytomel?
Cytomel has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 6,951 Cytomel users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Cytomel (liothyronine sodium)
- Lexapro (escitalopram oxalate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Lexapro:
- not at all: 4.08 %
- somewhat: 19.38 %
- moderate: 36.79 %
- high: 29.74 %
- very high: 10.01 %
Cytomel:
- not at all: 2.32 %
- somewhat: 18.74 %
- moderate: 31.31 %
- high: 32.41 %
- very high: 15.21 %
Want to compare Lexapro with Cytomel?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
Common Lexapro side effects:
- Fatigue (feeling of tiredness): 6,469 reports
- Stress and anxiety: 5,849 reports
- Pain: 5,093 reports
- Depression: 5,063 reports
- Headache (pain in head): 4,584 reports
- Drug ineffective: 4,383 reports
- Dizziness: 4,332 reports
Browse all side effects of Lexapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cytomel side effects:
- Fatigue (feeling of tiredness): 701 reports
- Drug ineffective: 565 reports
- Headache (pain in head): 466 reports
- Pain: 419 reports
- Stress and anxiety: 387 reports
- Weight increased: 384 reports
- Weakness: 362 reports
- Depression: 331 reports
Browse all side effects of Cytomel:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on escitalopram oxalate and liothyronine sodium (the active ingredients of Lexapro and Cytomel, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xyzal and Drug Level Increased - 2 seconds ago
- Xyzal and Infective Pulmonary Exacerbation Of Cystic Fibrosis - 4 seconds ago
- Xyzal and Electrocardiogram Qt Prolonged - 6 seconds ago
- Xyzal and Epilepsy - 9 seconds ago
- Xyzal and Drowsiness - 12 seconds ago
- Periactin and Gastroenteritis - 20 seconds ago
- Periactin and Oxygen Saturation Decreased - 22 seconds ago
- Periactin and Blood Alkaline Phosphatase Increased - 25 seconds ago
- Periactin and Disseminated Intravascular Coagulation - 29 seconds ago
- Periactin and Cardiac Failure - 31 seconds ago